Navigation Links
Researchers develop world's first biodegradable joint implant
Date:2/28/2012

Tampere University of Technology (TUT), Finland, has been the first in the world to develop biodegradable joint implant, RegJoint. The implant is used in the treatment of osteoarthritis and rheumatoid arthritis.

RegJoint has recently received CE Mark approval that allows the product to be sold in the European Union. The joint implant, which has been developed since the mid-1990s, is the result of collaboration between the Department of Biomedical Engineering at Tampere University of Technology, Conmed Linvatec Biomaterials, Scaffdex Ltd and a group of orthopaedic surgeons, among others, from Tampere University Hospital. Scaffdex Ltd will bring RegJoint to the market.

New treatment for arthritic patients

Rheumatoid arthritis and osteoarthritis destroy the normally smooth cartilage that lines the ends of bones. As cartilage regenerates poorly, the injuries are difficult to treat. Joint injury reduces mobility and causes pain. The conventional surgical options involve permanent implants or the artificial induction of joint ossification between two bones. RegJoint offers an alternative for conventional surgery and has several advantages over permanent implants. For example, the patient's own bone tissue remains intact during the operation. In addition, the implant makes the reconstruction of the joint more sustainable and cushions the area, relieving pain caused by friction between the bones.

The implant is used to repair injuries in the small joints of the fingers and toes. It is made of biodegradable polylactide copolymer and placed inside the joint capsule that surrounds the joint. The implant stimulates the body to produce connective tissue cells and is gradually replaced by the patient's own soft tissue. RegJoint forms a neojoint between the bone ends and restores normal mobility.

The product has undergone extensive clinical trials in Finland and abroad and patients have reported positive results.


'/>"/>

Contact: Minna Kellomki
minna.kellomaki@tut.fi
358-407-066-312
Tampere University of Technology
Source:Eurekalert

Related biology news :

1. Researchers identify novel pathway responsible for infection of a common STD pathogen
2. Researchers discover how vitamin D inhibits inflammation
3. Purdue researchers reveal role of protein mutation in Parkinsons disease
4. UVic researchers among presenters at global science conference
5. Researchers develop better control for DNA-based computations
6. Researchers warn nanoparticles in food, vitamins could harm human health
7. Worlds top technology researchers coming to Queens for TEI 2012
8. Researchers make living model of brain tumor
9. MDC researchers reveal molecular mechanism underlying severe anomalies of the forebrain
10. Grass to gas: UGA researchers genome map speeds biofuel development
11. Researchers develop new method for creating tissue engineering scaffolds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2020)... ... March 09, 2020 , ... ... rate of 64% last year, as enterprises sought to achieve competitive advantage ... Unfortunately, only 13% of all transformation efforts delivered the intended consequences. , ...
(Date:3/5/2020)... ... March 05, 2020 , ... Diagenode, a leading global provider ... a subsidiary of global genomics leader BGI Group, today announced a co-marketing agreement ... and Asia Pacific. , Under the terms of the non-exclusive agreement, the ...
(Date:3/4/2020)... ... March 04, 2020 , ... VGXI, Inc., a ... has been nominated as a finalist in the category of Best Contract Manufacturing ... VGXI expedites manufacturing of a DNA vaccine against the novel coronavirus, COVID-19, under ...
Breaking Biology News(10 mins):
(Date:3/10/2020)... (PRWEB) , ... March 10, ... ... a full-service cold chain biopharmaceutical engineering firm, is pleased to announce the ... is on combination medical device qualification and validation in the biopharmaceutical cold ...
(Date:3/4/2020)... REDCAR, England (PRWEB) , ... ... ... Antibody Ltd. , an industry-leading provider of recombinant antibody products and services, ... which offers customers the flexibility to rapidly express a large number of ...
(Date:3/3/2020)... , ... March 03, 2020 , ... ... the pharmaceutical, biotech and medical device industries, was recognized by INC. 5,000 on ... forward annual lists to note industry leaders greatly impacting their spheres of influence ...
(Date:3/2/2020)... ... March 02, 2020 , ... McBee, Moore and Vanik IP, LLC (MMV ... field of Biotechnology and Organics. , According to statistics compiled by Harrity Anaytics, MMV ... issued in technology center 1600 during 2019. Technology center 1600 at the US Patent ...
Breaking Biology Technology: